Clinical Research News at Jefferson
A newly funded DOE project will look at how LED lighting compares with standard fluorescent light for the health of people on regular daytime work schedules.
An FDA warning on epilepsy drugs may pose greater risk to patients.
Common prostate cancer therapy may increase short-term risk of death in patients with pre-existing cardiovascular conditions.
A change in the tumor metabolism due to tobacco exposure could open new treatment avenues in head and neck cancer.
Jefferson will become one of 48 centers in the world focused on Parkinson’s patient care, research, outreach and education, named by the Parkinson’s Foundation.
Jefferson researchers unveil first demonstration of heritable mutations behind non-alcoholic fatty liver disease.
Changing the route of entry for minimally invasive neurosurgery provides better outcomes for a wide range of interventions, and is preferred by patients.
New research may help change treatment practices for patients diagnosed with low risk thyroid cancer.